![Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology](https://www.frontiersin.org/files/Articles/469178/fonc-09-00863-HTML-r1/image_m/fonc-09-00863-g002.jpg)
Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology
![Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology](https://www.frontiersin.org/files/Articles/469178/fonc-09-00863-HTML-r1/image_m/fonc-09-00863-g001.jpg)
Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology
![Economica.net - În 7 minute poţi obţine un card de credit de la BCR. Este primul card de credit emis de o bancă în sistem exclusiv online - Economica.net Economica.net - În 7 minute poţi obţine un card de credit de la BCR. Este primul card de credit emis de o bancă în sistem exclusiv online - Economica.net](https://media-beta.romaniatv.net/unsafe/1020x574/smart/filters:contrast(5):format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/11/george_bcr_5768_23932000-747x420.jpg)